Literature DB >> 25653862

Managing complications in cirrhotic patients.

Markus Peck-Radosavljevic1, Paolo Angeli2, Juan Cordoba3, Oliver Farges4, Dominique Valla5.   

Abstract

Liver cirrhosis is a serious and potentially life-threatening condition. This life-threatening condition usually arises from complications of cirrhosis. While variceal bleeding is the most acute and probably best studied, several other complications of liver cirrhosis are more insidious in their onset but nevertheless more important for the long-term management and outcome of these patients. This review summarizes the topics discussed during the UEG-EASL Hepatology postgraduate course of the United European Gastroenterology Week 2013 and discusses emergency surgical conditions in cirrhotic patients, the management of hepatic encephalopathy, ascites and hepatorenal syndrome, coagulation disorders, and liver cancer.

Entities:  

Keywords:  Hepatic encephalopathy; ascites; cirrhosis; coagulation; coagulopathy; emergency; hepatocellular carcinoma; hepatorenal syndrome

Year:  2015        PMID: 25653862      PMCID: PMC4315683          DOI: 10.1177/2050640614560452

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  129 in total

1.  Vancomycin in resistant hepatic encephalopathy.

Authors:  A Forbes; I Murray-Lyon
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

Review 2.  Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis.

Authors:  P Deltenre; P Mathurin; S Dharancy; R Moreau; P Bulois; J Henrion; F R Pruvot; O Ernst; J C Paris; D Lebrec
Journal:  Liver Int       Date:  2005-04       Impact factor: 5.828

3.  Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis.

Authors:  Gennaro D'Amico; Angelo Luca; Alberto Morabito; Roberto Miraglia; Mario D'Amico
Journal:  Gastroenterology       Date:  2005-10       Impact factor: 22.682

4.  Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).

Authors:  Juan Cordoba; Meritxell Ventura-Cots; Macarena Simón-Talero; Àlex Amorós; Marco Pavesi; Hendrik Vilstrup; Paolo Angeli; Marco Domenicali; Pere Ginés; Mauro Bernardi; Vicente Arroyo
Journal:  J Hepatol       Date:  2013-10-12       Impact factor: 25.083

5.  Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.

Authors:  Antoni Mas; Juan Rodés; Lourdes Sunyer; Luís Rodrigo; Ramon Planas; Victor Vargas; Lluís Castells; Dolores Rodríguez-Martínez; Conrado Fernández-Rodríguez; Ignasi Coll; Albert Pardo
Journal:  J Hepatol       Date:  2003-01       Impact factor: 25.083

6.  Clinical characteristics of patients with hepatocellular carcinoma in Austria - is there a need for a structured screening program?

Authors:  Florian Hucke; Wolfgang Sieghart; Maximilian Schöniger-Hekele; Markus Peck-Radosavljevic; Christian Müller
Journal:  Wien Klin Wochenschr       Date:  2011-07-29       Impact factor: 1.704

7.  The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.

Authors:  Georgios Kalambokis; Michalis Economou; Andreas Fotopoulos; Jihad Al Bokharhii; Christos Pappas; Afroditi Katsaraki; Epameinondas V Tsianos
Journal:  Am J Gastroenterol       Date:  2005-04       Impact factor: 10.864

Review 8.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

9.  The importance of bacterial infections as precipating factors of chronic hepatic encephalopathy in cirrhosis.

Authors:  E Strauss; M F da Costa
Journal:  Hepatogastroenterology       Date:  1998 May-Jun

10.  Indomethacin-induced renal dysfunction in patients with well-compensated cirrhosis.

Authors:  F Wong; D Massie; P Hsu; F Dudley
Journal:  Gastroenterology       Date:  1993-03       Impact factor: 22.682

View more
  3 in total

1.  Bariatric Surgery in Cirrhotic Patients: Is It Safe?

Authors:  Hafsa Younus; Amit Sharma; Rosa Miquel; Alberto Quaglia; Subba Rao Kanchustambam; Kirstin A Carswell; Ameet G Patel
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

2.  Metabolic acidosis in critically ill patients with cirrhosis: Epidemiology and short-term mortality risk factors.

Authors:  Feng Gao; Miao-Tong Lin; Xing-Yi Yang; Meng-Xing Cai; Hao Nan; Wei Xie; Zhi-Ming Huang
Journal:  Turk J Gastroenterol       Date:  2019-10       Impact factor: 1.852

Review 3.  Diastolic dysfunction in cirrhosis.

Authors:  Søren Møller; Signe Wiese; Hanne Halgreen; Jens D Hove
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.